Genome Pharmaceuticals And Chemicals Private Limited - Company Profile

It is a chemicals and materials private limited company based in Mumbai, Maharashtra, India, established in 1994.
1994 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Genome Pharmaceuticals And Chemicals Private Limited

Genome Pharmaceuticals And Chemicals Private Limited, a active private limited company, was established on 01 August 1994 in Mumbai, Maharashtra, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U24231MH1994PTC079977. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.41 M.

It upholds a compliant status. Its leadership includes Ramanathan Sivaramakrishnan Iyer (Director), Sanjay Govind Prasad Ruia (Director), Udit Sanjay Ruia (Director). Past directors included Mahendra Kumar Kumawat, Ravikant F Sharma, Ramanathan Sivaramakrishnan Iyer. It holds ₹65.69 Cr open charges and ₹136.81 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-39 Nandjyot Industrialesatate Kurla Andheri Rd Safed Pool, Mumbai, Maharashtra, 400072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231MH1994PTC079977

  • Registration Number

    079977

  • Incorporation Date

    01 August 1994

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹2.41 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 2.41 M
  • Company Age 31 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 65.69 Cr
  • Satisfied Charges ₹ 136.81 Cr
  • Revenue Growth **** -23.67%
  • Profit Growth **** -22.81%
  • Ebitda **** 69.55%
  • Net Worth 8.59%
  • Total Assets **** 7.89%
Company report

Genome Pharmaceuticals And Chemicals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Genome Pharmaceuticals And Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Genome Pharmaceuticals And Chemicals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramanathan Sivaramakrishnan Iyer Director 24 Jan 2025 Current
Sanjay Govind Prasad Ruia Director 24 Jan 2025 Current
Udit Sanjay Ruia Director 20 Sep 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 04 Jul 2013 Past
Pramod Abcsdd Additional Director 24 Jul 2025 Past
Pramod Abcsdd Director 11 May 2011 Past
Pramod Abcsdd Director 20 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genome Pharmaceuticals And Chemicals.

Genome Pharmaceuticals And Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.67% decrease. The company also saw a substantial fall in profitability, with a 22.81% decrease in profit. The company's net worth moved up by a moderate rise of 8.59%.

Genome Pharmaceuticals And Chemicals revenue growth over time
Genome Pharmaceuticals And Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -23.67%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 7.89%
*******
*******
*******
*******
Profit or Loss
*******
 -22.81%
*******
*******
*******
*******
Net Worth
*******
 8.59%
*******
*******
*******
*******
EBITDA
*******
 69.55%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genome Pharmaceuticals And Chemicals?

Unlock access to Genome Pharmaceuticals And Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹656,900,000.00

Satisfied Charges

₹1,368,100,000.00

Charges Breakdown by Lending Institutions
  • Sbicap Trustee Company Limited : 65.69 Cr
Latest Charge Details
Date Lender Amount Status
24 Jul 2024 Sbicap Trustee Company Limited ₹65.69 Cr Open
06 Apr 2022 Others ₹3.08 Cr Satisfied
23 Jun 2021 Others ₹5.68 Cr Satisfied
25 Jul 2012 Others ₹36.00 Cr Satisfied
23 Mar 2011 Others ₹36.70 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Genome Pharmaceuticals And Chemicals?

Unlock and access historical data on people associated with Genome Pharmaceuticals And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genome Pharmaceuticals And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genome Pharmaceuticals And Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genome Pharmaceuticals And Chemicals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Genome Pharmaceuticals And Chemicals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Genome Pharmaceuticals And Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge registered on 23 Mar 2011 via Charge ID 10291427 with Others was fully satisfied on 21 Feb 2025. was documented.

  • Director Appointment

    Ramanathan Sivaramakrishnan Iyer was appointed as a Director was appointed as a Director on 24 Jan 2025 & has been associated with this company since 1 year 30 days . was recorded as a recent event.

  • Director Appointment

    The activity Sanjay Govind Prasad Ruia was appointed as a Director was appointed as a Director on 24 Jan 2025 & has been associated with this company since 1 year 30 days . was completed.

  • Director Appointment

    Udit Sanjay Ruia was appointed as a Director was appointed as a Director on 20 Sep 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genome Pharmaceuticals And Chemicals Private Limited?

The CIN of Genome Pharmaceuticals And Chemicals Private Limited is U24231MH1994PTC079977.

Where is Genome Pharmaceuticals And Chemicals Private Limited headquartered?

Genome Pharmaceuticals And Chemicals Private Limited is headquartered at A-39 Nandjyot Industrialesatate Kurla Andheri Rd Safed Pool, Mumbai, Maharashtra, 400072.

When was Genome Pharmaceuticals And Chemicals Private Limited incorporated?

Genome Pharmaceuticals And Chemicals Private Limited was incorporated on 01 August 1994.

Who are the current directors of Genome Pharmaceuticals And Chemicals Private Limited?

The current directors of Genome Pharmaceuticals And Chemicals Private Limited are

What is the primary industry of Genome Pharmaceuticals And Chemicals Private Limited?

The primary industry of Genome Pharmaceuticals And Chemicals Private Limited is Chemicals And Materials.

Is Genome Pharmaceuticals And Chemicals Private Limited a listed company?

Genome Pharmaceuticals And Chemicals Private Limited is unlisted.

What is the capital structure of Genome Pharmaceuticals And Chemicals Private Limited?

The authorized capital of Genome Pharmaceuticals And Chemicals Private Limited is ₹3.00 M, and the paid-up capital is ₹2.41 M.

What is the compliance status of Genome Pharmaceuticals And Chemicals Private Limited?

The compliance status of Genome Pharmaceuticals And Chemicals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available